Cutler Group LP Brainstorm Cell Therapeutics Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Cutler Group LP holds 100 shares of BCLI stock, worth $60. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$60% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
5Shares Held
500KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY386KShares$231,8480.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$57,0910.0% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$7,6110.03% of portfolio
-
Institutional & Family Asset Management, LLC6KShares$3,6000.0% of portfolio
-
Piershale Financial Group, Inc.100Shares$600.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $21.9M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...